MediWound Ltd.
NASDAQ: MDWD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ofer Gonen
- Employees
- 121
- Headquarters
- Yavne, Israel
- IPO year
- 2014
- Market cap
- $161.3M
- Website
- https://www.mediwound.com
Loading MDWD…
Loading profile data…Frequently asked questions about MDWD
What does MediWound Ltd. (MDWD) do?
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep p...
Where does MDWD trade?
MediWound Ltd. (MDWD) trades on the NASDAQ.
What sector is MDWD in?
MediWound Ltd. (MDWD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MediWound Ltd.?
Ofer Gonen is the chief executive officer of MediWound Ltd. (MDWD).
Where is MediWound Ltd. headquartered?
MediWound Ltd. is headquartered in Israel.
Does MDWD pay a dividend?
MediWound Ltd. (MDWD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MDWD go public?
MediWound Ltd. (MDWD) completed its initial public offering in 2014.